10% Off $75 Orders! Use Code SAVE10P Shop Now
One use per customer. Not available with Autoship. Expires 5/28/18.

Abstract: Pregabalin (Pfizer) – under development for pain of fibromyalgia

1 Star2 Stars3 Stars4 Stars5 Stars (31 votes, average: 3.10 out of 5)
Loading...

Curr Opin Investig Drugs. 2004 Jan;5(1):82-9.

[No authors listed]

Axovan Ltd., Innovation Center, Gewerbestrasse 16, CH-4123 Allschwil, Switzerland. richard.huckle@axovan.com

Pregabalin is a gamma-aminobutyric acid analog that is under development by Pfizer for the potential treatment of central nervous system disorders, including epilepsy, neuropathic pain, fibromyalgia and generalized anxiety disorder. By April 2003, Pfizer had filed for approval of pregabalin in Europe for neuropathic pain and as an adjunctive therapy for epilepsy, and in October 2003 an NDA was filed for these indications and generalized anxiety disorder. At this time, phase III trials in fibromyalgia were ongoing.

PMID: 14983979 [PubMed – in process]

1 Star2 Stars3 Stars4 Stars5 Stars (31 votes, average: 3.10 out of 5)
Loading...



Leave a Reply